Professor Peter Brennan, Consultant Oral and Maxillofacial Surgeon at Portsmouth Hospitals University NHS Trust, has been ...

The first patient, who had xerostomia linked with Sjögren's disease, received the autologous cell therapy as part of a Phase ...

ProstACT Global is trialling a promising new treatment option for prostate cancer, which is the most commonly diagnosed cancer and the second leading cause of cancer-related death for U.S. men. This ...